Changes in heart function in myocardial infarction rats following angiopoietin 1 gene modified bone marrow mesenchymal stem cell transplantation

Shu-hong Hou,Yi-qing Wang,Dong-ping Chen,Bing-bo Hou

DOI: https://doi.org/10.3969/j.issn.1673-8225.2009.19.012

2009-01-01

Abstract:BACKGROUND: Gene modified bone marrow mesenchymal stem cells (BMSCs) not only can express the gene characteristic, but also can promote the differentiate and survival rate of BMSCs. BMSCs modified angiopoietin-1 gene by the vehicle of lentiviral vector transplantation in the effect of rat heart function after myocardial infarction has not been reported. OBJECTIVE: To investigate the influence of grafted angiopoietin 1 (Ang1) gene modified rat BMSCs on angiogenesis and heart function following acute myocardial infarction. DESIGN, TIME AND SETTING: The randomized controlled animal study was performed at the Central Laboratory, First Affiliated Hospital, Fujian Medical University from August 2007 to August 2009. MATERIALS: A total of 48 clean male inbred line F344 rats were obtained from Shanghai Experimental Animal Center, Chinese Academy of Sciences. Lentivirus vector plasmid pNL-IRES2-EGFP, packaging plasmid pHELPER, and envelop plasmid pVSVG and 293T cells were gifted by Professor Chen Yi-ping from Tulane University, USA. Ang1 gene modified plasmids pNL-Ang1-IRES2-EGFP and rMSCs were presented by Professor Zhang Zhi-jian from Fujian Institute of Neurology. METHODS: Three plasmids pNL-Ang1-IRES2-EGFP (pNL-IRES2-EGFP), pHELPER and pVSVG were cotransfected into 293T to package lentiviral vector particles. The supernatant was collected after transfection and was concentrated by centrifugation. Then BMSCs were transduced with Ang1 gene modified lentiviral vector (Ang1-rMSCs) or lentiviral empty vector (Mock-rMSCs). Myocardial infarction model was established by ligating the left anterior descending coronary artery of the 48 F344 rats. Two weeks after surgery, 3 groups were set up, and rats in each group were respectively injected with Ang1-rMSCs, Mock-rMSCs and rMSCs into the border zone surrounding the infarct (5×1010/L). MAIN OUTCOME MEASURES: RT-PCR was used to determine Ang1 mRNA expression. Survival rate of BMSCs in the heart section was observed. Echocardiogram analysis was utilized to detect rat heart function. Immunofluorescence was employed to measure angiogenesis density. RESULTS: Ang1 gene rtiodified rMSCs were successfully obtained, and Ang1 mRNA was stably expressed at 28 days following transplantation. Under the fluorescence microscope, heart tissue frozen section was positive for EGFP in the Ang1-rMSCs and Mock-rMSCs groups, but negative in the rMSCs group at 28 days following transplantation. That is, the survival rate of Ang1-rMSCs significantly increased. Compared with the Mock-rMSCs and rMSCs groups, left ventricular ejection fraction and shortening fraction significantly increased in the Ang1-rMSCs group at 7 and 28 days following transplantation (P < 0.05), and heart function was significantly improved. Capillary density around the infarct area significantly increased (P < 0.05). CONCLUSION: Ang1 gene modified rMSCs may effectively promote angiogenesis and improve heart function in myocardial infarction rats.